Cell and gene therapy companies at Meeting on the Mesa 2026
141 cell and gene therapy companies are at Meeting on the Mesa 2026 — 91 presentations on the program. Most represented: Arbor Biotechnologies (1 on the program), Kyverna Therapeutics (1 on the program), REGENXBIO (1 on the program). 84 of them have their own page in this guide.
Focus area
Top represented
Showing 1–17 of 141 organizations
| Organization | Meeting on the Mesa 2026 Attendance |
|---|---|
Arbor Biotechnologies Cambridge, MA | ◇Silver Sponsor |
Develops gene-editing therapeutics for genetic diseases, including liver and central nervous system conditions and rare disorders. | Spotlight Mon, Oct 5 10:45am Innovation Spotlight company presentation Panel Wed, Oct 7 4:15pm |
Kyverna Therapeutics Emeryville, CA | ◇Silver Sponsor |
Develops CAR T-cell therapies for autoimmune diseases, including autologous and allogeneic products with rapid manufacturing processes. | Spotlight Mon, Oct 5 2:30pm Innovation Spotlight company presentation Panel Wed, Oct 7 |
REGENXBIO Rockville, MD | ◇Silver Sponsor |
Develops AAV gene therapies for retinal and rare diseases, including programs for wet AMD, diabetic retinopathy, Duchenne muscular dystrophy, and MPS II. | Spotlight Mon, Oct 5 11:00am Innovation Spotlight company presentation |
Rocket Pharmaceuticals, Inc. Cranbury, NJ | ◇Silver Sponsor |
Develops gene therapies for rare cardiovascular diseases, with additional programs in hematology and immunology and proprietary AAV manufacturing capabilities. | Spotlight Mon, Oct 5 11:30am Innovation Spotlight company presentation Panel Wed, Oct 7 |
Kenai Therapeutics San Diego, CA | ◇Silver Sponsor |
Develops off-the-shelf allogeneic neuron replacement and gene-modified cell therapies for Parkinson’s disease and other neurological conditions. | Spotlight Mon, Oct 5 2:45pm Innovation Spotlight company presentation |
Tenaya Therapeutics South San Francisco, CA | ◇Silver Sponsor |
Develops gene therapies and regenerative cell treatments for rare genetic disorders and other heart diseases. | Spotlight Tue, Oct 6 12:00pm Innovation Spotlight company presentation |
uniQure Amsterdam, Netherlands | ◇Silver Sponsor |
Develops one-time gene therapies for hemophilia, Huntington’s disease, epilepsy, Fabry disease, and other severe conditions. | Spotlight Mon, Oct 5 3:15pm Innovation Spotlight company presentation |
Cabaletta Bio Philadelphia, PA | ◇Silver Sponsor |
Develops engineered T-cell therapies for autoimmune diseases. | Panel Wed, Oct 7 |
◇Silver Sponsor | |
Develops programmed T-cell therapies for cancer and autoimmune diseases, with candidates targeting blood cancers, solid tumors and autoimmune conditions. | Panel Wed, Oct 7 |
Iovance San Carlos, CA | ◇Silver Sponsor |
Develops tumor-infiltrating lymphocyte therapies for cancer, including Amtagvi, an approved cell therapy for advanced melanoma. | Workshop Wed, Oct 7 8:00am |
Miromatrix Eden Prairie, MN | ◆Diamond Sponsor |
Develops bioengineered, transplantable human organs using decellularized scaffolds and recellularization technology. | Chair Wed, Oct 7 |
Ocugen Malvern, PA | ◇Silver Sponsor |
Develops gene and cell therapies for inherited retinal diseases, blindness and other serious conditions. | Panel Wed, Oct 7 |
Beam Therapeutics Cambridge, MA | ◇Silver Sponsor |
Develops base-editing medicines that precisely modify genes to treat serious diseases. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
BlueRock Therapeutics Cambridge, MA | ◇Silver Sponsor |
Develops engineered cell therapies using pluripotent stem cells and genome editing for neurological, cardiac, and immune diseases. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Editas Medicine Cambridge, MA | ◇Silver Sponsor |
Develops CRISPR-based gene-editing medicines for genetic diseases. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Solid Biosciences Charlestown, MA | ◇Silver Sponsor |
Develops genetic medicines for Duchenne muscular dystrophy and other serious diseases, including gene therapies and genetic medicines for cardiac conditions. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Artiva Biotherapeutics San Diego, CA | |
Develops off-the-shelf allogeneic natural killer cell therapies designed to deplete B cells in autoimmune diseases. | Spotlight Tue, Oct 6 3:00pm Innovation Spotlight company presentation Chair Wed, Oct 7 Panel Wed, Oct 7 11:15am |
Instantly find 20 buyers from cell and gene therapy companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Meeting on the Mesa 2026 by
Organization type
Focus area
Everyone
Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction